ROBERTS ZACHARY (EVP of R&D) sold 4.1% of their position (26.27K shares) of ALLOGENE THERAPEUTICS, INC. on the open market
Open‑market sale worth $41.0K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 1/23/2026ACC: 0001851044-26-000003
Officer· EVP of R&D
Since Feb 2026
-26.27K
Net shares
Net seller
$41.0K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
26.27K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−26.27K
Price / share
$1.56
Trade value
$40.98K
% of position
4.1%
1/21/2026
643.13K→616.87K
Total
Net shares
−26.27K
Net value
-$40.98K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/21/2026 | S · Sale | −26.27K | $1.56 | $40.98K | 4.1% | 643.13K | 616.87K |
| Total | −26.27K | -$40.98K | ||||||
Derivative Transactions0
No derivative transactions reported